Entering text into the input field will update the search result below

Amneal and Mylan weigh on generic players

  • Generic drug makers are mostly in the red in apparent sympathy with drops in Amneal Pharmaceuticals (-33% on restructuring and softer guidance) and Mylan (-5% on continued EpiPen shortage).
  • Selected tickers: Aclaris Therapeutics (ACRS -4.7%), Akorn (AKRX -2.8%), Amphastar Pharmaceuticals (AMPH), ANI Pharmaceuticals (ANIP -2%), Bausch Health Companies (BHC -0.8%), Teva Pharmaceutical Industries (TEVA -3.6%), Coherus BioSciences (CHRS -1.8%), Collegium Pharmaceutical (COLL -0.9%), Eagle Pharmaceuticals (EGRX -1.8%), Endo International (ENDP -2.8%), Lannett Company (LCI +0.2%), Mallinckrodt (MNK -0.8%), Perrigo (PRGO -1.2%), Dr. Reddy's Laboratories (RDY -1.3%), Teligent (TLGT -2.8%)

Recommended For You

Related Stocks

SymbolLast Price% Chg
ACRS--
Aclaris Therapeutics, Inc.
AKRXQ--
Akorn, Inc.
AMPH--
Amphastar Pharmaceuticals, Inc.
ANIP--
ANI Pharmaceuticals, Inc.
BHC--
Bausch Health Companies Inc.